Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11 HKD
120.03 M HKD
934.10 M HKD
255.39 M
About SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD
Sector
CEO
Da Jun Zhao
Headquarters
Shanghai
Website
Founded
1996
ISIN
CNE1000000W4
FIGI
BBG000NYGLN0
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. engages in research and development and commercialization of drugs. Its research and development platforms include genetic technical platform, photodynamic platform, nano technical platform and oral solid preparation platform. The company’s products include ALA on photodynamic technical platform, LIBOd on nano technical platform and all kinds of diagnostic reagents on diagnosis technology platform. Shanghai Fudan Zhangjiang Bio Pharmaceutical was founded by Jun Li, Hai Bo Wang and Da Jun Zhao on November 11, 1996 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1349 is 2.95 HKD — it has increased by 0.34% in the past 24 hours. Watch SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stocks are traded under the ticker 1349.
1349 stock has risen by 10.49% compared to the previous week, the month change is a −2.64% fall, over the last year SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM has showed a 15.23% increase.
1349 reached its all-time high on Jun 1, 2015 with the price of 12.64 HKD, and its all-time low was 0.01 HKD and was reached on Mar 3, 2008. View more price dynamics on 1349 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1349 stock is 2.41% volatile and has beta coefficient of 1.59. Track SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM there?
Today SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM has the market capitalization of 3.05 B, it has decreased by −9.93% over the last week.
Yes, you can track SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financials in yearly and quarterly reports right on TradingView.
SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
1349 net income for the last quarter is 17.41 M HKD, while the quarter before that showed 73.54 M HKD of net income which accounts for −76.33% change. Track more SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financial stats to get the full picture.
SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM dividend yield was 2.97% in 2023, and payout ratio reached 65.20%. The year before the numbers were 2.30% and 51.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 11, 2024, the company has 948.00 employees. See our rating of the largest employees — is SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM on this list?
Like other stocks, 1349 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock shows the buy signal. See more of SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.